Piramal Pharma Ltd.

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue1,117873.111,0831,0571,578
Expenses1,052914.01987.13967.591,216
EBITDA152.4343.27175.24158.64442.83
EBIT99.42-7.10124.41107.08390.33
Profit Before Tax65.64-40.9096.1989.66362.67
Net Profit41.70-33.3677.1674.34273.08
Financial Ratios
Operating Profit Margin14.45%5.11%17.63%15.49%29.03%
Net Profit Margin3.95%-3.94%7.76%7.26%17.90%
Earning Per Share (Diluted)0.35-0.280.610.562.06
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.9.8
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ